2021 Videos Archives

Global Standardization of Flow Cytometry Results with AI Systems

2025-06-11T10:26:19-07:00December 8th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars|

Watch video

Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality

2025-06-11T10:27:17-07:00October 28th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars|

Watch video

Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations

2025-06-11T10:28:13-07:00August 24th, 2021|2021 Videos, Featured Videos, Videos|

Watch video

A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System

2026-03-09T18:06:14-07:00July 15th, 2021|2021 Videos, 2021 Webinars, Featured Videos, Videos, Webinars|

Watch video

Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma

2025-06-11T10:30:05-07:00June 14th, 2021|2021 Videos, Featured Videos, Videos|

Watch video

New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma

2025-06-11T10:39:30-07:00June 14th, 2021|2021 Videos, Featured Videos, Videos|

Watch video

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

Global Standardization of Flow Cytometry Results with AI Systems

Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality

Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations

A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System

Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma

New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

Global Standardization of Flow Cytometry Results with AI Systems

Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality

Critical Mistakes to Avoid when Developing a Drug/CDx Combination for International Registrations

A Streamlined Laboratory Workflow for Controlling Antibody and Reagent Lots on a 12C Flow Cytometry System

Assessment of MRD by NGS in Daily Clinical Management of Multiple Myeloma

New Frontiers in Hematology: From CLL Tumor Precursor Cells to Tracking Disease Burden in Multiple Myeloma

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.